AMCP Market Insights: Navigating the rapidly changing landscape of ER+/HER2- metastatic breast cancer.
This publication summarizes a virtual expert panel discussion convened by AMCP Market Insights in February 2025, focusin...
ASO Author Reflections: Vascular Resection in Perihilar Cholangiocarcinoma Surgery.
- Post category:Breast Cancer
- Reading time:1 min read
The publication presents an analysis focused on optimizing surgical and systemic treatment strategies for a specific can...
Evaluating mammographic density’s contribution to improve a breast cancer risk model with questionnaire-based and polygenic factors.
- Post category:Breast Cancer
- Reading time:1 min read
This study assessed the added value of incorporating BI-RADS mammographic breast density into a breast cancer risk model...
Suppressing protein damage response to overcome multidrug resistance in cancer therapy.
- Post category:Breast Cancer
- Reading time:1 min read
This study identifies a novel mechanism underlying multidrug resistance in cancer involving direct binding of anticancer...
Contemporary Nodal Management and Overall Survival of Older Patients with HR-/HER2+ Breast Cancer.
- Post category:Breast Cancer
- Reading time:1 min read
This study evaluated surgical nodal management in women aged 70 years or older with early to locally advanced HR-/HER2+...
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer.
- Post category:Breast Cancer
- Reading time:1 min read
This study analyzed tumor-specific MHC-II (tsMHC-II) expression as a predictive biomarker in the phase III NeoTRIP trial...